Acadia Pharmaceuticals reported $602.49M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
ALKERMES ALKS:US USD 1.94B 15.52M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Aptinyx Inc APTX:US USD 76.2M 16.1M
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bristol Myers Squibb BMY:US USD 98.2B 2.16B
Cara Therapeutics CARA:US USD 213.51M 13.06M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Cytokinetics CYTK:US USD 1.08B 304.24M
Eisai 4523:JP JPY 1.26T 11.59B
Eli Lilly And LLY:US USD 47.46B 397.9M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
Intra Cellular Therapies ITCI:US USD 782M 29.91M
Marinus Pharmaceuticals MRNS:US USD 184.84M 75.46M
Moderna Inc MRNA:US USD 26.06B 13M
Neurocrine Biosciences NBIX:US USD 2.14B 137.7M
Prothena PRTA:US USD 554.44M 4.85M
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Seattle Genetics SGEN:US USD 3.62B 11.26M
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Vanda Pharmaceuticals VNDA:US USD 621.79M 12.69M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
YTE INCY:US USD 5.51B 191.18M